First drug to treat underlying cause of cystic fibrosis approved in the US
01 February 2012
Sukaina Virji
Please Login to read the full article.
01 February 2012
Sukaina Virji
Please Login to read the full article.
RELATED CONTENT
NEWS
- Vertex gains 55% on surprising interim data from Kalydeco combo in cystic fibrosis
- Vertex' Q1 launch of CF drug Kalydeco impresses, with 60% penetration
- New gene therapy for cystic fibrosis to undergo Phase II testing in the UK
- Researchers: Vertex's Kalydeco a big step, but combination approach may be leap
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
